145 related articles for article (PubMed ID: 16046580)
21. Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: evidence for possible autocrine regulation of the primate corpus luteum by progesterone.
Duffy DM; Hess DL; Stouffer RL
J Clin Endocrinol Metab; 1994 Dec; 79(6):1587-94. PubMed ID: 7989460
[TBL] [Abstract][Full Text] [Related]
22. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
Ottobre JS; Stouffer RL
Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
[TBL] [Abstract][Full Text] [Related]
23. Effect of late follicular phase administration of antide on ovulation and inhibin secretion in macaques.
Fraser HM; Lunn SF; Cowen GM; Smith KB; Conn PM
Contraception; 1991 Dec; 44(6):667-76. PubMed ID: 1773623
[TBL] [Abstract][Full Text] [Related]
24. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women.
Beckers NG; Platteau P; Eijkemans MJ; Macklon NS; de Jong FH; Devroey P; Fauser BC
Eur J Endocrinol; 2006 Aug; 155(2):355-63. PubMed ID: 16868151
[TBL] [Abstract][Full Text] [Related]
25. Effects of FSH on serum immunoreactive inhibin levels in the luteal phase of the menstrual cycle.
Burger H; Hee J; Bangah M; Prince M; McCloud P; Ohara A; Iwai T; Mori T
Clin Endocrinol (Oxf); 1996 Oct; 45(4):431-4. PubMed ID: 8959081
[TBL] [Abstract][Full Text] [Related]
26. SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.
Fraser HM; Duncan WC
Reprod Fertil Dev; 2009; 21(3):377-92. PubMed ID: 19261215
[TBL] [Abstract][Full Text] [Related]
27. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
Hutchison JS; Zeleznik AJ
Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
29. Immunoreactive inhibin concentrations in serum throughout the menstrual cycle of the macaque: suppression of inhibin during the luteal phase after treatment with an LHRH antagonist.
Fraser HM; Robertson DM; De Kretser DM
J Endocrinol; 1989 Apr; 121(1):R9-12. PubMed ID: 2497222
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary.
Ravindranath N; Little-Ihrig L; Phillips HS; Ferrara N; Zeleznik AJ
Endocrinology; 1992 Jul; 131(1):254-60. PubMed ID: 1612003
[TBL] [Abstract][Full Text] [Related]
31. Role of vascular endothelial growth factor in ovarian physiology - an overview.
Kaczmarek MM; Schams D; Ziecik AJ
Reprod Biol; 2005 Jul; 5(2):111-36. PubMed ID: 16100562
[TBL] [Abstract][Full Text] [Related]
32. Immunoneutralization and immunocytochemical localization of inhibin alpha subunit during the mid-luteal phase in the stump-tailed macaque.
Fraser HM; Smith KB; Lunn SF; Cowen GM; Morris K; McNeilly AS
J Endocrinol; 1992 Jun; 133(3):341-7. PubMed ID: 1613435
[TBL] [Abstract][Full Text] [Related]
33. Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitor-treated rats.
Sakurai T; Tamura K; Kogo H
Eur J Pharmacol; 2005 Jun; 516(2):158-64. PubMed ID: 15921676
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of inhibin A and inhibin B in women with normal and abnormal luteal function.
Yamoto M; Imai M; Otani H; Nakano R
Obstet Gynecol; 1997 May; 89(5 Pt 1):773-6. PubMed ID: 9166319
[TBL] [Abstract][Full Text] [Related]
35. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support.
Hutchison JS; Zeleznik AJ
Endocrinology; 1985 Sep; 117(3):1043-9. PubMed ID: 3893990
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of circulating concentrations of gonadotropins and ovarian hormones throughout the menstrual cycle in the bonnet monkey: role of inhibin A in the regulation of follicle-stimulating hormone secretion.
Suresh PS; Medhamurthy R
Am J Primatol; 2009 Oct; 71(10):817-24. PubMed ID: 19452529
[TBL] [Abstract][Full Text] [Related]
37. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
Scotti L; Abramovich D; Pascuali N; Irusta G; Meresman G; Tesone M; Parborell F
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():392-401. PubMed ID: 25151950
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory effect of luteinizing hormone, insulin-like growth factor-1, and epidermal growth factor on vascular endothelial growth factor production in cultured bubaline luteal cells.
Chouhan VS; Dangi SS; Babitha V; Verma MR; Bag S; Singh G; Sarkar M
Theriogenology; 2015 Oct; 84(7):1185-96. PubMed ID: 26242566
[TBL] [Abstract][Full Text] [Related]
39. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
40. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
